Search results

Order by most recent / most popular / relevance

Results: 1-10 of 18

The FTC weighs in on recent state efforts to promotehinder healthcare competition from APRNs

Baker & Hostetler LLP
-
USA
-
May 2 2013

In recent years, the Federal Trade Commission (FTC) frequently has commented on state efforts to either expand or restrict competition faced by

Promoting healthcare competition the FTC’s recent comments on state legislativeregulatory efforts impacting competition from APRNs

Baker & Hostetler LLP
-
USA
-
April 30 2013

In recent years, the Federal Trade Commission ("FTC") has frequently commented on state efforts to either expand, or restrict competition faced by

Most favored nation clauses - state ban ends antitrust action against Michigan blues

Baker & Hostetler LLP
-
USA
-
April 4 2013

In the wake of the passage of a Michigan statute and regulatory order banning the use of most favored nation (MFN) clauses by insurers, health

Do not pass go, do not collect $200: Michigan statute and regulatory order banning MFN provisions in provider contracts ends government antitrust lawsuit against Michigan Blue

Baker & Hostetler LLP
-
USA
-
March 26 2013

In the wake of the passage of a Michigan statute and regulatory order banning the use of most favored nation ("MFN") clauses by insurers, health

“Wide-ranging investigation” leads FTC and Idaho AG to join ongoing antitrust lawsuit challenging acquisition of Idaho’s largest independent, multi-specialty physician group

Baker & Hostetler LLP
-
USA
-
March 19 2013

After dodging an attempt by two of its competitors to stop the closing of its acquisition of Saltzer Medical Group (“Saltzer”)a for-profit

Supreme Court holds antitrust law applies to state hospital authority transaction

Baker & Hostetler LLP
-
USA
-
February 21 2013

In one of the most closely watched healthcare antitrust cases in years, the Supreme Court issued its decision in the FTC merger challenge to a

No standing for illegal drugs: Third Circuit limits antitrust standing for foreign drug manufacturers absent FDA approval

Baker & Hostetler LLP
-
USA
-
February 7 2013

A Third Circuit panel recently ruled that a foreign drug manufacturer lacks antitrust standing when it could only sell its product in the United

When will they learn? Doctors continue to face antitrust charges for jointly negotiating contracts without clinical or financial integration

Baker & Hostetler LLP
-
USA
-
January 29 2013

Legitimate joint marketing and selling arrangements have the potential to produce efficiencies. This is particularly so, for example, where the

Justice Department clears NY Hospital Association gainsharing program

Baker & Hostetler LLP
-
USA
-
January 24 2013

The U.S. Department of Justice (DOJ) has found no antitrust obstacles to a physician gainsharing program that the Greater New York Hospital

Dr. Goldilocks and the three bears: GAO assesses antitrust guidance for provider collaborations

Baker & Hostetler LLP
-
USA
-
April 26 2012

The U.S. Government Accountability Office (GAO) issued a report on April 16 assessing the adequacy of antitrust guidance for collaborations among competing healthcare providers

next >